Suraksha Diagnostic Ltd

BSE Code : 544293
NSE Symbol : SURAKSHA
ISIN : INE877V01027
Industry :HEALTHCARE

Trade Now

Get Quotes

323.70 0.55(0.17%)

Open Price (₹)

320.00

Prev. Close (₹)

323.15

Volume (No’s)

184,518

Market Cap (₹)

1,682.99

Low Price (₹)

318.60

High Price (₹)

327.05 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
21-May-2025	28-May-2025	Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday 28 May 2025 at the registered office of the Company to inter-alia consider and approve the audited (standalone and consolidated) financial results of the Company for the quarter and financial year ended 31 March 2025. and to consider recommendation of dividend if any on equity shares of the Company for the financial year ended 31 March 2025. Outcome of Board meeting held on 28 May 2025 inter-alia for approval of financial results for the quarter and financial year ended 31 March 2025. (As Per BSE Announcement Dated on :28.05.2025)
27-Mar-2025	27-Mar-2025	Information about acquisition
03-Feb-2025	08-Feb-2025	Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended 31 December 2024 1. The unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended 31 December 2024 and the same is enclosed along with the Limited Review Report issued by the Statutory Auditors of the Company. 2. Appointment of Mr. Ravindra K S as the Chief Financial Officer with effect from 01 March 2025, who will also act as a Group Chief Financial Officer. 3. Amended Policies of the Company. (As Per Bse Announcement Dated on 08.02.2025)
14-Dec-2024	20-Dec-2024	Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/12/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 20 December 2024 at the registered office of the Company inter-alia to consider approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter and six months ended 30 September 2024. 1.Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter and six months ended 30 September 2024; 2. Postal Ballot Notice for seeking shareholders' approval for the ratification of 'Suraksha Employee Stock Option Scheme 2024' ('ESOP 2024'/ 'Scheme')3. Formation of a Special Purpose Vehicle Company ('SPV') (As per BSE Announcement Dated on 20/12/2024) Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for incorporation of Suraksha Advanced Radiology Private Limited, Subsidiary of the Company. (As Per BSE Announcement dated on 22.01.2025)